These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 20540061)

  • 21. Selective descriptor pruning for QSAR/QSPR studies using artificial neural networks.
    Turner JV; Cutler DJ; Spence I; Maddalena DJ
    J Comput Chem; 2003 May; 24(7):891-7. PubMed ID: 12692798
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bayesian screening for active compounds in high-dimensional chemical spaces combining property descriptors and molecular fingerprints.
    Vogt M; Bajorath J
    Chem Biol Drug Des; 2008 Jan; 71(1):8-14. PubMed ID: 18069988
    [TBL] [Abstract][Full Text] [Related]  

  • 23. QSAR modelling of HIV-1 reverse transcriptase inhibition by benzoxazinones using a combination of P_VSA and pharmacophore feature descriptors.
    Balaji S; Karthikeyan C; Moorthy NS; Trivedi P
    Bioorg Med Chem Lett; 2004 Dec; 14(24):6089-94. PubMed ID: 15546736
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MIA-QSAR evaluation of a series of sulfonylurea herbicides.
    Bitencourt M; Freitas MP
    Pest Manag Sci; 2008 Aug; 64(8):800-7. PubMed ID: 18338340
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bayesian-regularized genetic neural networks applied to the modeling of non-peptide antagonists for the human luteinizing hormone-releasing hormone receptor.
    Fernández M; Caballero J
    J Mol Graph Model; 2006 Dec; 25(4):410-22. PubMed ID: 16574448
    [TBL] [Abstract][Full Text] [Related]  

  • 26. QSAR analysis of salicylamide isosteres with the use of quantum chemical molecular descriptors.
    Dolezal R; Van Damme S; Bultinck P; Waisser K
    Eur J Med Chem; 2009 Feb; 44(2):869-76. PubMed ID: 18547684
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bayesian similarity searching in high-dimensional descriptor spaces combined with Kullback-Leibler descriptor divergence analysis.
    Vogt M; Bajorath J
    J Chem Inf Model; 2008 Feb; 48(2):247-55. PubMed ID: 18229907
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prediction and mechanistic interpretation of human oral drug absorption using MI-QSAR analysis.
    Iyer M; Tseng YJ; Senese CL; Liu J; Hopfinger AJ
    Mol Pharm; 2007; 4(2):218-31. PubMed ID: 17397237
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of mutual information and genetic programming for feature selection in QSAR.
    Venkatraman V; Dalby AR; Yang ZR
    J Chem Inf Comput Sci; 2004; 44(5):1686-92. PubMed ID: 15446827
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interpreting computational neural network QSAR models: a measure of descriptor importance.
    Guha R; Jurs PC
    J Chem Inf Model; 2005; 45(3):800-6. PubMed ID: 15921469
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Combinatorial QSAR modeling of specificity and subtype selectivity of ligands binding to serotonin receptors 5HT1E and 5HT1F.
    Wang XS; Tang H; Golbraikh A; Tropsha A
    J Chem Inf Model; 2008 May; 48(5):997-1013. PubMed ID: 18470978
    [TBL] [Abstract][Full Text] [Related]  

  • 32. QSAR--how good is it in practice? Comparison of descriptor sets on an unbiased cross section of corporate data sets.
    Gedeck P; Rohde B; Bartels C
    J Chem Inf Model; 2006; 46(5):1924-36. PubMed ID: 16995723
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Development predictive QSAR models for artemisinin analogues by various feature selection methods: a comparative study.
    Abbasitabar F; Zare-Shahabadi V
    SAR QSAR Environ Res; 2012 Jan; 23(1-2):1-15. PubMed ID: 22040327
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Linear and non-linear QSAR modelling of juvenile hormone esterase inhibitors.
    Devillers J; Doucet JP; Doucet-Panaye A; Decourtye A; Aupinel P
    SAR QSAR Environ Res; 2012; 23(3-4):357-69. PubMed ID: 22443267
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A combinatorial feature selection approach to describe the QSAR of dual site inhibitors of acetylcholinesterase.
    Asadabadi EB; Abdolmaleki P; Barkooie SM; Jahandideh S; Rezaei MA
    Comput Biol Med; 2009 Dec; 39(12):1089-95. PubMed ID: 19854437
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Predicting MDCK cell permeation coefficients of organic molecules using membrane-interaction QSAR analysis.
    Chen LL; Yao J; Yang JB; Yang J
    Acta Pharmacol Sin; 2005 Nov; 26(11):1322-33. PubMed ID: 16225754
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Strategic selection of chemicals for testing. Part I. Functionalities and performance of basic selection methods.
    Aladjov H; Todorov M; Schmieder P; Serafimova R; Mekenyan O; Veith G
    SAR QSAR Environ Res; 2009; 20(1-2):159-83. PubMed ID: 19343590
    [TBL] [Abstract][Full Text] [Related]  

  • 38. QSAR modeling using chirality descriptors derived from molecular topology.
    Golbraikh A; Tropsha A
    J Chem Inf Comput Sci; 2003; 43(1):144-54. PubMed ID: 12546547
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecule kernels: a descriptor- and alignment-free quantitative structure-activity relationship approach.
    Mohr JA; Jain BJ; Obermayer K
    J Chem Inf Model; 2008 Sep; 48(9):1868-81. PubMed ID: 18767832
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Stochastic versus stepwise strategies for quantitative structure-activity relationship generation--how much effort may the mining for successful QSAR models take?
    Horvath D; Bonachera F; Solov'ev V; Gaudin C; Varnek A
    J Chem Inf Model; 2007; 47(3):927-39. PubMed ID: 17480052
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.